US Oncology, Inc. Announces Retirement of R. Dale Ross and Appointment of Bruce Broussard as Chairman of the Board

THE WOODLANDS, Texas, Aug. 5 /PRNewswire/ -- Today, the Board of Directors of US Oncology Holdings, Inc. and its wholly owned subsidiary, US Oncology, Inc. (collectively, "US Oncology" or the "Company"), announced that, effective Sept. 1, 2009, R. Dale Ross is retiring as Executive Chairman and from the Board of Directors. At that time, Bruce Broussard, the Company's CEO and President, will also become Chairman of the Board.

Broussard joined US Oncology in August 2000 as its Chief Financial Officer, assumed responsibility of the Pharmacy division in September 2003, was appointed President in November 2005 and became CEO in February 2008. In his new role as Chairman of the Board, Broussard will retain his positions as CEO and President. Broussard stated, "It has been a privilege to work with Dale over the past nine years, and I am grateful for his leadership and mentoring. I wish him the best in retirement and his ongoing support and counsel."

Russell Carson, a member of the Company's Board of Directors since 1992 and General Partner of Welsh, Carson, Anderson & Stowe, the Company's largest stockholder, said "The Board accepts Dale's decision to retire with regret, but enormous gratitude. Thanks to his leadership, foresight and development of a talented and committed management team, the Company has strengthened its position as a leading company serving the entire oncology field, and I thank Dale for all his accomplishments, both personal and professional. The Board is confident that Bruce will continue to lead the organization in an innovative and disciplined manner and in furthering the Company's mission."

US Oncology's expertise in supporting aspects of the cancer care delivery system - from drug development to distribution and outcomes measurement - enables the Company to help increase the efficiency and safety of cancer care. US Oncology is affiliated with 1,236 physicians operating in 476 locations, including 94 radiation oncology facilities in 39 states. For more information, visit the Company's website, www.usoncology.com.

US Oncology Holdings, Inc.


MORE ON THIS TOPIC